Compounds > 3-n-methylspiperone
Page last updated: 2024-09-03

3-n-methylspiperone and pimavanserin

3-n-methylspiperone has been researched along with pimavanserin in 1 studies

Compound Research Comparison

Studies
(3-n-methylspiperone)		Trials
(3-n-methylspiperone)		Recent Studies (post-2010)
(3-n-methylspiperone)		Studies
(pimavanserin)		Trials
(pimavanserin)		Recent Studies (post-2010) (pimavanserin)
1556715923134

Protein Interaction Comparison

ProteinTaxonomy3-n-methylspiperone (IC50)pimavanserin (IC50)
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0335
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0464
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0464
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.41

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J1

Reviews

1 review(s) available for 3-n-methylspiperone and pimavanserin

ArticleYear
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
    Journal of medicinal chemistry, 2022, 08-25, Volume: 65, Issue:16

    Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin

2022